LDH、CRP在重症及难治性肺炎支原体肺炎诊断中的临床应用价值  

Clinical Application Value of LDH and CRP in the Diagnosis of Severe and Refractory Mycoplasma Pneumoniae Pneumonia

作　　者：罗玲云[1] 邱基庆 曹冰冰 严美洁 

机构地区：[1]广东省佛山市高明区人民医院儿科,广东佛山528500

出　　处：《临床医学工程》2018年第1期67-68,共2页Clinical Medicine & Engineering

摘　　要：目的研究分析乳酸脱氢酶(LDH)、C-反应蛋白(CRP)在重症及难治性肺炎支原体肺炎诊断中的临床应用价值。方法选取我院2016年7月至2017年7月收治的50例肺炎支原体肺炎患儿,依据其病情程度分为实验Ⅰ组(27例,轻症肺炎支原体肺炎)、实验Ⅱ组(23例,重症及难治性肺炎支原体肺炎),另选取同期于我院进行健康体检的50例儿童作为对照组。比较三组儿童的LDH、CRP水平。结果实验Ⅰ组与实验Ⅱ组的LDH、CRP水平均高于对照组,且实验Ⅱ组的LDH、CRP水平高于实验Ⅰ组,差异均有统计学意义(P<0.05)。结论 LDH、CRP可作为早期预测重症及难治性肺炎支原体肺炎的重要指标。Objective To study and analyze the clinical application value of lactate dehydrogenase （LDH） and C-reactive protein （CRP） in the diagnosis of severe and refractory mycoplasma pneumoniae pneumonia. Methods 50 cases of children with mycoplasma pneumoniae pneumonia admitted to our hospital from July 2016 to July 2017 were selected and divided into experimental group Ⅰ （27 cases, mild mycoplasma pneumoniae pneumonia） and experimental group Ⅱ （23 cases, severe and refractory mycoplasma pneumoniae pneumonia） according to their severity. Another 50 cases of children undergoing healthy physical examination in our hospital during the same period were selected as the control group. The LDH and CRP levels of three groups were compared. Results The LDH and CRP levels of experimental group Ⅰ and group Ⅱ were higher than those of control group, and the LDH and CRP levels of experimental group Ⅱ were higher than those of experimental group Ⅰ, with statistical differences （P〈0.05）. Conclusions LDH and CRP can be used as the important indicators for early prediction of severe and refractory mycoplasma pneumoniae pneumonia.

关 键 词：乳酸脱氢酶 C-反应蛋白 重症及难治性肺炎支原体肺炎 

分 类 号：R725.6[医药卫生—儿科]